Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Limited has announced the cessation of 395,395 performance rights due to unmet conditions, as of April 26, 2024. This development could indicate changes in the company’s performance metrics or strategic direction, likely to interest investors and market watchers.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.